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Diabetes mellitus is a collection of symptoms that arise in someone who has increased blood glucose levels. 
The Stevia plant (Stevia rebaudiana Bert) contains a compound of diterpene glycosides as steviosida and 
rebaudiosida A. Purified extract of steviosida and rebaudiosida A is widely used as a sweetener for low 
calorie food and beverage products or as a sugar substitute for diabetics and has the effect of lowering 
blood sugar levels. This study aims to determine the antidiabetic effect of microencapsulated preparations 
of Stevia leaf extract (Stevia rebaudiana) with a combination of inulin chitosan encapsulation. Antidiabetic 
mellitus test was carried out in vivo using test animals of male white rats of Wistar strain. The inducing 
compound that can cause the condition of diabetes mellitus test animals is Aloxan with a dose of 150 mg / 
kg Body weight of rats. given intraperitoneally for one day, then the mice were allowed to stand for 3 days 
to reach a state of diabetes mellitus. Blood glucose levels of test animals were measured on days 1 (initial), 
5 (induction) and 12 (treatment) to determine the initial blood glucose levels, after induction of alloxan 
and after administration of test compounds both CMC Na 0.5% , glibenclamide, and preparations 
microencapsulation of Stevia leaf extract at a dose of 100; 300; and 700 mg / kg body weight. The results 
were obtained after 7 days of treatment, it was seen that blood glucose levels in the CMC group remained 
high, while the Glibenclamid administration group, and the three dosages of microencapsulation 
preparations of Stevia leaf extract could reduce blood glucose levels. This can be seen from the statistical 
test that there is a significant difference (p <0.05) between the CMC group and the Glibenclamide group, 
and microencapsulation preparations of Stevia leaf extract. Microencapsulation preparations of Stevia leaf 
extract can reduce blood glucose levels with an effective dose of 100 mg / kg body weight.  
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Diabetes Mellitus is a disease when the 
body cannot produce insulin [1]. Insulin 
hormone deficiency causes interference with 
biochemical processes in the body, which is a 
decrease in glucose uptake into cells and an 
increase in glucose from the liver to the 
circulation [2]. This disease is the most common 
metabolic syndrome in the whole world with an 
incidence of 1-8%. Long-term manifestations of 
diabetes can cause several microvascular 
complications and macrovascular [3]. There are 
2 types of DM disease, namely DM type 1, a 
condition wherein the deficiency of insulin 
production by the pancreas, this condition can 
only be treated with insulin. Type 2 diabetes 
that occurs due to the body's inability to 
respond appropriately to the activity of insulin 
produced by the pancreas (insulin resistance), 
so that no normal glucose levels in the blood are 
reached [4].  
Stevia leaf (Stevia rebaudiana Bertoni) is a 
plant that has been used lately. The main 
content of stevia leaves are steviol derivatives, 
especially steviosid (4-15%), rebausid A (2-4%) 
and C (1-2%) and dulcocide A (0.4-0.7%) [5]. 
Many people use it as a natural sweetener. The 
sweet taste of stevia leaves obtained from the 
substance ofpenpenic glycosides called steviol 
contained from stevia leaves [6]. Stevia is a low-
calorie sweetener that is safe for consumption 
by people with diabetes mellitus and is believed 
to be able to reduce blood glucose levels 
because it contains steviosida, rebaudiosida and 
a number of antioxidants [5]. Synthetic 
antioxidant compounds and naturally able to 
control glucose levels in the blood and prevent 
complications of diabetes [7]. Stevioside 
compounds in stevia can inhibit the absorption 
of glucose in the intestine and the formation of 
glucose in the liver by changing the activity of 
enzymes that play a role in the synthesis of 
glucose, so that glucose levels in the blood 
plasma are reduced [8].  
This study aims to determine the anti-
diabetic effect of microencapsulated 
preparations of Stevia leaf extract (Stevia 
rebaudiana). Microencapsulation needs to be 
done to maintain the active components in the 
stevia leaf extract and to cover any deficiencies 
of stevia. The usefulness of this technique 
includes controlling the release of active 
compounds from medicinal substances, making 
the active compounds safer, protecting 
substances that are sensitive to their 
environment [9], protecting the effects of 
undesirable effects due to the effects of light, 
moisture and oxygen [10]. 
 
2. Experimental section  
2.1. Tools and Materials used 
The tools used are spray dryer (Buchi Mini 
Spray Dryer B-29-), rotary vacuum evaporator 
(Buchi R-114), Scanning Electron Microscope 
(JEOL JSM-5310LV-20 kV), analytical balance, 
homogenizer (Ultra Turrax ® T50 Basic ), 
spectrophotometer (UV-Vis Mini Shimadzu U-
1240), rotary-evaporator, cabinet drying, 
grinder, analytical balance (Mettler H80), 
spatula, cuvette, centrifuge, and glassware. The 
materials used in this study consisted of stevia 
leaves obtained from Solo. Inulin, chitosan, 1% 
acetic acid, Tween 80 1%, male rats of Wistar 
strain, ethanol, alloxan monohydrate, glucose, 
sucrose, saccharin, aquabides, and the GOD-PAP 
enzyme. 
2.2. Microencapsulation of Stevia Leaf 
Extract 
The microencapsulation of Stevia leaf 
extract made an emulsion system with an inulin: 
chitosan encapsulation ratio of 25: 75b / b. 
Chitosan is dissolved in 1% acetic acid and then 
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Tween 80 1% emulsifiers are added. 
Furthermore, inulin is put into chitosan solution 
and homogenized using Homogenizer Ultra 
Turrax ® T50 Basic with a speed of 5000 rpm 
for 5 minutes. Furthermore, the 
microencapsulation process of stevia leaf 
extract is carried out using the spray drying 
method at a feed rate of 15 ml / min and inlet 
temperature of 120°C.  
2.3. Measurement of Blood Sugar Levels 
Rats that had been fasting for 12 hours and 
had been measured fasting blood sugar levels, 
were then given a treatment feed 
(microencapsulation of stevia leaf extract) dose 
of 100; 300 and 700 mg/kg body weight with 
the administration of drinking by ad libitum 
(unlimited). Furthermore, rats were measured 
their blood sugar levels after eating [11]. As a 
positive control, Glibenklamid was given a dose 
of 0.45 mg/kg Body Weight for 6 days. 
 
3. Results and Discussion 
This study aims to determine the 
antidiabetic effect of microencapsulated 
preparations of Stevia leaf extract (Stevia 
rebaudiana). Antidiabetic mellitus test was 
carried out in vivo using test animals of male 
white rats of Wistar strain. The selection of male 
white rats is intended to avoid the existence of a 
hormonal cycle (estrous cycle) which is likely to 
affect the metabolic processes in the body that 
can affect the results of research. The inducing 
compound that can cause the condition of the 
diabetes mellitus test animal is Aloxan with a 
dose of 150 mg / kg Body Weight of rats. Alloxan 
solution in aquabidest was given 
intraperitoneally for one day, then the rats were 
allowed to stand for 3 days to reach a state of 
dissolved diabetes mellitus.  
Alloxan is selectively toxic to pancreatic 
beta cells that produce insulin due to the 
accumulation of alloxan specifically through 
glucose transporters, namely GLUT2 [12]. Its 
diabetogenic effect is antagonistic to 
glutathione which reacts with the SH group. 
Aloxan reacts by destroying the essential 
substances in the pancreatic beta cells, causing 
the reduction of insulin-carrying granules in the 
pancreatic beta cells [13]. Cytotoxic action of 
alloxan is mediated by free radicals. The toxic 
action of alloxan on beta cells is initiated by free 
radicals formed by redox reactions. Alloxan and 
its reduction product, dialuric acid, form a redox 
cycle with superoxide radical formation. This 
radical undergoes dismutase into hydrogen 
peroxide. Hydroxyl radicals with high reactivity 
formed by the Fenton reaction. The action of 
free radicals with high stimulation increases the 
concentration of calcium cytosol which causes 
rapid destruction of beta cells [12].  
Blood glucose levels of test animals were 
measured on days 1 (initial), 5 (induction) and 
12 (treatment) to determine the initial blood 
glucose levels, after induction of alloxan and 
after administration of test compounds both 
0.5% CMC Na, glibenclamide, and preparations 
microencapsulation of Stevia leaf extract with 
three doses. Mean blood glucose levels, percent 
increase and percent decrease in all treatment 




Table 1. Average Blood Glucose Levels  until (mg/dl), Percentage of Increase and Percentage of Decrease in All Treatment Groups 
Group 
Blood Glucose Levels  until (mg/dl) 
%  Increase %  Decrease 
Initial Induction Treatment 
CMC Na 0,5 %  103.7510 323.25107* 415.25135 208.3582 -29.8015b 
Glibenclamide 0.63 mg / kg  Body Weight  of rats  83.5037 296.5094* 83.7523 310.24236 71.167a 
Microencapsulation of Stevia leaf extract of 100 mg / kg  Body Weight 129.5077 392.25229* 104.2553 207.22114 70.819a 
Microencapsulation of Stevia leaf extract of 300 mg / kg  Body Weight 153.7574 240.2539* 85.5012 78.7463 64.223a 
Microencapsulation of Stevia leaf extract of 700 mg / kg  Body Weight 124.5052 270.5098* 79.7527 155.23157 67.2217a 
Description: 
*: paired sample t test kg early vs induction which showed significantly different values (p<0.05) 
a: significantly different (p <0.05) against the negative group with the Mann-Whitney test 
b: significantly different (p <0.05) against the positive group with the Mann-Whitney test 
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Based on table 1, blood glucose levels in all 
treatment groups showed an increase of more 
than 50 percent after alloxan induction. After 7 
days of treatment, it was seen that the blood 
glucose level in the CMC group remained high, 
while the Glibenclamid administration group, 
and the three dosages of microencapsulation 
preparations of Stevia leaf extract could reduce 
blood glucose levels. This can be seen from the 
statistical test that there is a significant 
difference between the CMC group and the 
Glibenclamide group, and microencapsulation 
preparations of Stevia leaf extract at a dose of 
100; 300; and 700 mg / kg body weight. In 
addition, the comparison between the 
Glibenclamide group and microencapsulation 
preparations of Stevia leaf extracts of the three 
doses showed insignificant differences. This 
means that the antidiabetic effect of mellitus 
microencapsulation of Stevia leaf extracts in 
three doses is comparable to Glibenklamid. 
Based on this it is proved that the 
microencapsulation preparation of Stevia leaf 
extract can reduce blood glucose levels with an 
effective dose of 100 mg / kg Body Weight or 
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Microencapsulation preparations of Stevia 
leaf extract can increase percent reduction in 
blood glucose levels. Microencapsulation of 
Stevia leaf extract has been proven to reduce 
blood glucose levels by decreasing in the range 
of 60-80%. Microencapsulation is a process of 
encapsulating active ingredients designed to 
protect wrapped materials from factors that can 
reduce the quality of these ingredients [14]. 
Microencapsulation needs to be done to 
maintain the active components in the stevia 
leaf extract and to cover any deficiencies of 
stevia. 
The mechanism of action of Stevia leaves in 
lowering blood glucose levels is due to the 
compounds of stevioside glycosides and steviol 
can stimulate insulin secretion through direct 
action on pancreatic beta cells and can repair 
damage to pancreatic beta cells, which leads to 
an increase in carbohydrate metabolism 
enzymes so as to form normal glucose levels 
[15]. Antidiabetic effects may be caused by 
steviosides which counteract glucotoxicity in 
cells β [16] or also by suppressing glucagon 
secretion by pancreatic α cells [17].  
 
 
4. Conclusion  
Microencapsulation preparations of Stevia 
leaf extract with a dose can reduce blood 
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